Moderna, Inc. (MRNA) Stock Price Today
Key Stats
- $26.76BMarket Cap
- -Volume
- HealthSector
- $81.8052W High
- $22.3652W Low
- -Typical Hold Time
- $22.85BEnterprise Value
- -Div Yield
- -Trading Activity
Track Moderna, Inc. (MRNA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $81.8, highlighting its annual price range. Buy and sell Moderna, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Most Recent News
Japanese firms use NVIDIA Nemotron to build AI tailored for local industries and workforce needs.
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
ARCpoint delays annual financial filings due to funding issues, expects to file by Sept 29, 2026.
ARCpoint Inc. announced it will likely miss the July 29, 2026 deadline to file its annual financial statements and related reports due to a lack of funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and awaits ap...
Investors in Putnam mutual funds may claim losses in a new class action lawsuit.
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.